Showing results (31-40 of 103) with videos related to
Sort By:
Pageof 11
Current Opinion in Ophthalmology|April 17, 2007
Value-based medicine and interventions for macular degenerationMelissa M Brown, Gary C Brown, Heidi BrownThe American Journal of the Medical Sciences|July 24, 2019
Ethnicity and Diabetic Quality-of-LifeGary C Brown, Melissa M Brown, Sanjay SharmaRetinal Cases & Brief Reports|February 2, 2016
RUPTURED RETINAL ARTERIAL MACROANEURYSM ON THE OPTIC DISKEhsan Rahimy, Brian C Doyle, Gary C BrownOcular Immunology and Inflammation|October 21, 2003
Value-based medicine: evidence-based medicine and beyondGary C Brown, Melissa M Brown, Sanjay SharmaOphthalmology|July 13, 2014
Twenty-four-month efficacy and safety of 0.5 mg or 2.0 mg ranibizumab in patients with subfoveal neovascular age-related macular degenerationAllen C Ho, Brandon G Busbee, Carl D Regillo, et al.Current Opinion in Ophthalmology|May 1, 2004
Dollars and sight: the economics of ophthalmologyLindsay M Smithen, Gary C Brown, Melissa M BrownCurrent Opinion in Ophthalmology|May 5, 2005
The macroeconomics of vitreoretinal diseasesGeorge J Ko, Melissa M Brown, Gary C BrownOphthalmology. Retina|November 19, 2023
Cost-Utility Analysis of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular DegenerationGary C Brown, Melissa M Brown, Meg C MonigleEuropean Journal of Ophthalmology|January 31, 2019
Vision utilities in Italy and the United States: Comparison of time tradeoff vision utilitiesGabriella De Salvo, Gary C Brown, Melissa M BrownOphthalmology|August 8, 2015
Photopsias: A Key to DiagnosisGary C Brown, Melissa M Brown, David H FischerPageof 11